FindTrial
Sign In

ACTOR – AUC Control of Tacrolimus in Organ Recipients

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-527107-22-00
Enrollment
24
Registered
2026-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplantation

Brief summary

AUC0-12 (rich sampled)

Detailed description

AUC0-12 (limited sampling, 3 points), intra-individual coefficient of variation (CV%) of the AUC0-12/C0 ratio, microbiome metagenomics

Interventions

DRUGPROGRAF 1 mg capsule

Sponsors

Oslo Universitetssykehus HF
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
AUC0-12 (rich sampled)—

Secondary

MeasureTime frame
AUC0-12 (limited sampling, 3 points), intra-individual coefficient of variation (CV%) of the AUC0-12/C0 ratio, microbiome metagenomics—

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 5, 2026